• 17.10.2019 – 17:34

  

  The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB

  more

  One document

• 12.07.2019 – 17:04

  

  High investor density at the Pitch Day hosted by IZB

  more

  One document

• 26.06.2019 – 16:59

  

  ChromoTek has launched next level of secondary antibodies

  more

  One document